Orthofix Medical Announces Participation in Upcoming UBS Global Healthcare Conference
Orthofix Medical Announces Participation in Upcoming UBS Global Healthcare Conference
Orthofix Medical Inc. (NASDAQ:OFIX) announced that CEO Jon Serbousek and CFO Doug Rice will present at the UBS Global Healthcare investor conference on May 23, 2022, at 2:45 p.m. ET.
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
LEWISVILLE, Texas--(BUSINESS WIRE)--
Orthofix Medical Inc. (NASDAQ:OFIX), a global medical device company with a spine and orthopedics focus, today announced that President and Chief Executive Officer Jon Serbousek and Chief Financial Officer Doug Rice will participate in the upcoming UBS Global Healthcareinvestor conference. Mr. Serbousek will be presenting on Monday, May 23, 2022 at 2:45 p.m. ET. The conference will be held live at the Lotte New York Palace in New York, NY.
Orthofix Medical Inc. is a global medical device company with a spine and orthopedics focus. The Company’s mission is to deliver innovative, quality-driven solutions while partnering with health care professionals to improve patient mobility. Headquartered in Lewisville, Texas, Orthofix’s spine and orthopedics products are distributed in more than 60 countries via the Company's sales representatives and distributors. For more information, please visit www.orthofix.com.